Reference-grade research compound
Sermorelin Acetate
Sermorelin acetate; GRF(1-29)-NH2, the acetate salt of an amidated synthetic 29-residue N-terminal fragment of human growth hormone-releasing hormone
Sequence schematic — no PDB structure deposited
- Scientific name
- Sermorelin acetate; GRF(1-29)-NH2, the acetate salt of an amidated synthetic 29-residue N-terminal fragment of human growth hormone-releasing hormone
- Sequence
- YADAIFTNSYRKVLGQLSARKLLQDIMSR
- Length
- 29-mer
- Molecular formula
- C149H246N44O42S
- Molecular weight
- 3357.96 g/mol
- Form
- lyophilized
- Available sizes
- 5 mg, 10 mg
- Storage
- Store lyophilized powder at −20 °C, desiccated and protected from light. Stable for 24 months.
- Batch HPLC purity
- 99.4%
Description
Amidated 29-residue peptide corresponding to the biologically active N-terminal fragment of human growth hormone-releasing hormone. Used in vitro as a reference compound in GHRH receptor binding assays and adenylate cyclase signaling model systems. Supplied as a lyophilized acetate salt.
Current batch
RR-SERMORELINACETATE-260326-B
Manufactured Mar 26, 2026
Tested Apr 1, 2026
Storage and stability
Store lyophilized powder at −20 °C, desiccated and protected from light. Stable for 24 months.
Peer-reviewed references
Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency.
BioDrugs · 1999
PMID 18031173PubMedAdvances in the detection of growth hormone releasing hormone synthetic analogs.
Drug Test Anal · 2021
PMID 34665524PubMedGHRH agonist MR-409 protects β-cells from streptozotocin-induced diabetes.
Proc Natl Acad Sci U S A · 2023
PMID 37307472PubMed
Titles and journals pulled from PubMed and cached for 7 days. Links open in a new tab.